Business Segments · Capital expenditures, gross
Life Sciences — Capital expenditures, gross
Danaher Life Sciences — Capital expenditures, gross decreased by 52.6% to $27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 43.8%, from $48M to $27M. Over 2 years (FY 2023 to FY 2025), Life Sciences — Capital expenditures, gross shows a downward trend with a -23.8% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026Apr 21, 2026
Rolls up toProperty, plant, and equipment additions
How to read this metric
Higher spending indicates investment in future capacity, while lower spending may suggest a focus on cash preservation or completed expansion cycles.
Detailed definition
The total cash outflow for the acquisition or improvement of long-term physical assets within the Life Sciences segment....
Peer comparison
Standard metric for capital investment; peers in the life sciences space will report similar figures based on their growth stage.
Metric ID:
dhr_segment_life_sciences_capital_expenditures_grossHistorical Data
13 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $80M | $80M | $80M | $80M | $60M | $50M | $52M | $229M | $48M | $41M | $40M | $57M | $27M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -25.0% | -16.7% | +4.0% | +340.4% | -79.0% | -14.6% | -2.4% | +42.5% | -52.6% |
| YoY Change | — | — | — | — | -25.0% | -37.5% | -35.0% | +186.3% | -20.0% | -18.0% | -23.1% | -75.1% | -43.8% |
Range$27M – $229M
CAGR-30.4%
Avg YoY Growth-10.1%
Median YoY Growth-25.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's life sciences — capital expenditures, gross?
- Danaher (DHR) reported life sciences — capital expenditures, gross of $27M in Q1 2026.
- How has Danaher's life sciences — capital expenditures, gross changed year-over-year?
- Danaher's life sciences — capital expenditures, gross decreased by 43.8% year-over-year, from $48M to $27M.
- What is the long-term trend for Danaher's life sciences — capital expenditures, gross?
- Over 2 years (2023 to 2025), Danaher's life sciences — capital expenditures, gross has grown at a -23.8% compound annual growth rate (CAGR), from $320M to $186M.
- What does life sciences — capital expenditures, gross mean?
- Total spending on physical assets like machinery and facilities for the Life Sciences unit.